当前位置:首页 > 科研成果 > 本所论文
论文题目 刊物名称 发表年度
Disulfide bridge-targeted metabolome mining unravels an antiparkinsonian peptide ACTA PHARMACEUTICA SINICA B 2024
Structural and Computational Insights into the Noncanonical Aromatization in Fungal Polyketide Biosynthesis ACS CATALYSIS 2024
Christensenella strain resources, genomic/metabolomic profiling, and association with host at species level GUT MICROBES 2024
Microbiota-gut-brain axis: interplay between microbiota, barrier function and lymphatic system GUT MICROBES 2024
Members of the class Candidatus Ordosarchaeia imply an alternative evolutionary scenario from methanogens to haloarchaea ISME JOURNAL 2024
Adaptive plasticity of natural interleukin-35-induced regulatory T cells (Tr35) that are required for T-cell immune regulation THERANOSTICS 2024
Oxidation of Biogenic U(IV) in the Presence of Bioreduced Clay Minerals and Organic Ligands ENVIRONMENTAL SCIENCE & TECHNOLOGY 2024
Sphingobium sp. SJ10-10 encodes a not-yet-reported chromate reductase and the classical Rieske dioxygenases to simultaneously degrade PAH and reduce chromate JOURNAL OF HAZARDOUS MATERIALS 2024
The extracellular cyclophilin A-integrin β2 complex as a therapeutic target of viral pneumonia MOLECULAR THERAPY 2024
Heterotrophic nitrification by Alcaligenes faecalis links organic and inorganic nitrogen metabolism ISME JOURNAL 2024
A Verticillium dahliae exoglucanase as potential HIGS target interacts with a cotton cysteine protease to confer resistance to cotton Verticillium wilt PLANT BIOTECHNOLOGY JOURNAL 2024
Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid JOURNAL OF NANOBIOTECHNOLOGY 2024
Unleashing the potential: type I CRISPR-Cas systems in actinomycetes for genome editing NATURAL PRODUCT REPORTS 2024
Differential phosphorylation of Ca2+-permeable channel CYCLIC NUCLEOTIDE-GATED CHANNEL20 modulates calcium-mediated freezing tolerance in Arabidopsis PLANT CELL 2024
LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis EMBO MOLECULAR MEDICINE 2024